Your browser doesn't support javascript.
loading
Lack of association between modifiable exposures and glioma risk: a Mendelian randomization analysis.
Saunders, Charlie N; Cornish, Alex J; Kinnersley, Ben; Law, Philip J; Claus, Elizabeth B; Il'yasova, Dora; Schildkraut, Joellen; Barnholtz-Sloan, Jill S; Olson, Sara H; Bernstein, Jonine L; Lai, Rose K; Chanock, Stephen; Rajaraman, Preetha; Johansen, Christoffer; Jenkins, Robert B; Melin, Beatrice S; Wrensch, Margaret R; Sanson, Marc; Bondy, Melissa L; Houlston, Richard S.
Afiliação
  • Saunders CN; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Cornish AJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Kinnersley B; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Law PJ; Division of Genetics and Epidemiology, The Institute of Cancer Research, London, UK.
  • Claus EB; School of Public Health, Yale University, New Haven, Connecticut, USA.
  • Il'yasova D; Department of Neurosurgery, Brigham and Women's Hospital, Boston, Massachusetts, USA.
  • Schildkraut J; Department of Epidemiology and Biostatistics, School of Public Health, Georgia State University, Atlanta, Georgia, USA.
  • Barnholtz-Sloan JS; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Olson SH; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Bernstein JL; Duke Cancer Institute, Duke University Medical Center, Durham, North Carolina, USA.
  • Lai RK; Cancer Control and Prevention Program, Department of Community and Family Medicine, Duke University Medical Center, Durham, North Carolina, USA.
  • Chanock S; Department of Population and Quantitative Health Sciences and the Cleveland Center for Health Outcomes Research, Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
  • Rajaraman P; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Johansen C; Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, New York, USA.
  • Jenkins RB; Departments of Neurology and Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, California, USA.
  • Melin BS; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Wrensch MR; Division of Cancer Epidemiology and Genetics, National Cancer Institute, Bethesda, Maryland, USA.
  • Sanson M; Danish Cancer Society Research Center, Survivorship, Danish Cancer Society, Copenhagen, Denmark.
  • Bondy ML; Oncology Clinic, Finsen Centre, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Houlston RS; Department of Laboratory Medicine and Pathology, Mayo Clinic Comprehensive Cancer Center, Mayo Clinic, Rochester, Minnesota, USA.
Neuro Oncol ; 22(2): 207-215, 2020 02 20.
Article em En | MEDLINE | ID: mdl-31665421
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Encefálicas / Glioma Idioma: En Ano de publicação: 2020 Tipo de documento: Article